Dr. Rena Buckstein from Odette Cancer Centre in Toronto shares the basics of myelodysplastic syndromes (MDS) diagnosis, treatment, and side effects.

In Canada, it is estimated that up to 5,900 new cases of MDS are diagnosed each year - most often in older adults.

There are two main types of MDS: primary (de novo) and secondary MDS. The treatment for MDS varies according to the type and stage of the disease with the goal of slowing or stopping the MDS from becoming acute myeloid leukemia (AML).

For more information about MDS, visit:

https://www.bloodcancers.ca/i-have-blood-cancer/myelodysplastic-syndromes